Allurion Technologies Inc. (ALUR) Research

Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.

Market snapshot

Symbol
ALUR
Price
$0.58
Day change
-1.69%
Market cap
$4.4M
P/E ratio
-2.32x
52-week range
0.551-49.95
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$3.00

Peer companies

  • Adaptimmune Therapeutics plc (ADAP)
  • Aethlon Medical, Inc. (AEMD)
  • Envoy Medical, Inc. (COCH)
  • Co-Diagnostics, Inc. (CODX)
  • Ernexa Therapeutics Inc. (ERNA)
  • Lifeward Ltd. (LFWD)
  • enVVeno Medical Corporation (NVNO)
  • ProPhase Labs, Inc. (PRPH)

Recent insider activity

  • Gibbons Brendan M. — trade (0 shares) on 2025-12-31
  • Buch Ojas — trade (0 shares) on 2025-12-31
  • Davin Michael R — G-Gift (604 shares) on 2025-10-03
  • Davin Michael R — G-Gift (2608 shares) on 2025-11-26
  • Davin Michael R — S-Sale (1606 shares) on 2025-12-03

Open Allurion Technologies Inc. (ALUR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.